Kumuda Company
A new approach to drug discovery
Total Funding:
120000.0
Headquarters:
Boston, Massachusetts, United States
Funding Status:
Seed
Employee Number:
1-10
Estimated Revenue:
$1M to $10M
Last Funding Type:
Pre-Seed
Technology:
Immunotherapy
Last Funding Date:
2020-01-17
Investors Number:
1.0
Founded Date:
2020-01-01
Industry:
Early Drug Development